drugset / Trial / NCT03928808

Fecal Microbiota Transplantation (FMT) in Treatment of Severe and Enduring Anorexia Nervosa

NCT03928808

NaSingle-groupOpen-labelOther

Summary

This is an open-label pilot study designed to explore the safety, feasibility, tolerability, and acceptability of fecal microbiota transplantation (FMT) in the treatment of severe and enduring anorexia nervosa (SE-AN).

Timeline

Start
2023-04-01
Primary completion
2024-03
Completion
2024-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal Microbiota Transplantation (FMT) Other / unclassified 30 ml Other

Indications